Our consultants

Victoria Webber was appointed as a Consultant Breast Surgeon in the Edinburgh Breast Unit 2021. She studied at the University of Edinburgh Medical School and did her general surgery training in both Edinburgh and Glasgow. Victoria took some time out of training to complete her MD with the Edinburgh Breast Cancer Now Research team and the University of Edinburgh and wrote my thesis on endocrine resistance in patients with ER positive/ HER2 positive breast cancers. In her clinical practice she performs a range of oncoplastic breast surgery techniques and remains actively involved with the University of Edinburgh as the lead for breast surgery on the MSc Surgical Sciences, as well as teaching the undergraduate medical students. As an educational supervisor she enjoys working with surgical trainees as they develop their skills and progress in their training pathways.

Dr Campbell graduated from the University of Edinburgh in 2000.  During her oncology training she completed a Fellowship in Radiation Oncology at the Odette Cancer Centre in Toronto.  She has been a Consultant Clinical Oncologist since 2010, specialising in thoracic and upper gastro-intestinal malignancies.  Dr Campbell is also a member of the stereotactic radiotherapy group for the management of oligometastes.  She is an investigator on a number of academic and commercial trials, helping to drive forward the treatment of our oncology patients and is involved in the training of the next generation of clinical oncologists in my role as a Clinical and Educational Supervisor.

Dr Barrie completed his first degree in Biomedical Science and subsequently obtained his medical degree in 2008. He completed speciality training in Medical Oncology in Edinburgh in 2018,  with some time spent at the Beatson Cancer Centre.

He specialises in the drug treatment of thoracic cancers and Cancers of Unknown primary with  a specialist interest in the use of Immunotherapy and targeted therapies. He is the principal investigator on several drug trials in advanced lung cancer.

In addition to his clinical role he is active in medical education and is a educational and clinical supervisor for medical oncology trainees.

Dr Reid is a Palliative Medicine Consultant who has worked in cancer services since 2000. She completed specialty training and then worked for 12 years as a Palliative Medicine Consultant in the South West of England. In her last post she held various clinical, governance and educational leadership roles. Having made the decision to return home, she joined NHS Lothian in 2018. Dr Reid was appointed as Clinical Director for Palliative Care in 2019 and AMD for cancer services in 2022. She is committed to the delivery of timely, high quality and safe interventions for patients with cancer, and care that is in keeping with their individual values. She has three daughters, none of whom chose medicine.

I studied Biomedical Science at Kings College, London, before graduating from Medicine in Edinburgh in 2008. As a junior doctor I developed an interest in Anticipatory care planning and was part of the National Do Not Attempt Cardio-Pulmonary Resuscitation (DNACPR) policy working group. I have published papers on DNACPR, ACP QI work improving access to patient Key Information Summaries at the front door. Latterly, I completed an MD and published papers on Rehabilitative Palliative Medicine and now am part of a European Association for Palliative Care Task force in this field.

My role within the Hospital Palliative Care Team includes provision of support at the ‘front door’ at the Western General Hospital, supporting the acute medical teams with Supportive and Palliative Medicine. I believe that incorporating a rehabilitative goal centred approach for patients with palliative care needs is vital for person-centered care.

Outside of Palliative Medicine I enjoy mountain biking, walks with family, and have completed the ‘Tough Mudder’ and ‘MacTuff’: any excuse to get muddy!

Dr Malik is a Consultant in Clinical Oncology at the Edinburgh Cancer Centre and an Honorary Senior Clinical Lecturer at the University of Edinburgh. His main clinical interests are in urological cancers especially prostate, renal, bladder and germ cell cancers. He has extensive experience in clinical trials related to urological cancers, advanced radiotherapy techniques (SABR, VMAT and brachytherapy) and has been a principal investigator on several practice change urological cancer trials.

Professor Symeonides is a Medical Oncologist and Senior Clinical Lecturer at the Institute of Genetics and Cancer (University of Edinburgh) and at the linked Edinburgh Cancer Centre (NHS Lothian); he also has a Pharmaceutical Medicine role in CRUK’s Centre for Drug Development. After clinical training in the UK (Cambridge, Edinburgh), Australia (Melbourne) & New Zealand (Christchurch), and research in academia, clinic & industry, he now leads the Edinburgh Experimental Cancer Medicine Centre, where he provides the link between Edinburgh’s laboratory discoveries and their clinical development. In the clinic, he runs the Edinburgh Phase I Cancer Trials Unit and recently stepped down from a specialty interest in renal cancer to take on an increased Medical Advisor role in CRUK’s Centre for Drug Development. His research spans cytotoxic, small molecule, metabolic and even psychological therapies, but his main focus is immunotherapies, where he is the clinical lead for the Edinburgh Cancer Immunology network.

Dr Brown undertook his medical oncology training in Edinburgh, completed a Clinical Fellowship in Toronto, Canada and then completed a PhD in translational melanoma research with the University of Edinburgh. He has been a Consultant in Medical Oncology at the Edinburgh Cancer Centre since 2009. His main clinical interests are colorectal cancer, melanoma, clinical trials and global oncology. Dr Brown is UK Chief Investigator for several clinical trials in melanoma, Chair of the Melanoma SIGN Guideline group, and Clinical Lead for SACT Services for South-East Scotland. His work is supported by an NHS Research Scotland Career Researcher Award (2013-2023).